West Nile Virus
14
3
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Investigating Visuo-spatial Abilities and Psychological Effects in West Nile and Multiple Sclerosis Patients with a Focus on a Possible Rehabilitation Protocol
Early Interferon-beta Treatment for West-Nile Virus Infection
West Nile Virus Seroprevalence Under Bird Ringers
A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults
Prospective Investigation of Oxidative Stress in West Nile Virus Infection
Natural History of West Nile Virus Infection
Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Retrovirus Epidemiology Donor Study-II (REDS-II)
West Nile Virus Natural History
IVIG - West Nile Encephalitis: Safety and Efficacy
Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020